PeptideStack
5.2kquestions
20kanswers
220users

What does a payer actually need to see in a prior-authorisation request?

Asked 19 May 2026Modified 14 days agoViewed 1.5k times
1

I would like to understand the process rather than be told to try harder.

I am trying to do this correctly the first time rather than learn it by getting it wrong.

I have already made one mistake here that cost me a vial, so I am being deliberately careful.

What does a defensible version of this look like in practice?

prior-authorization
prior-authorization

Prior authorisation mechanics: medical-necessity criteria, documenting a lifestyle-intervention requirement, step therapy, and the…

19 questions
insurance
insurance

Coverage: formulary tiers, exclusion versus non-coverage, the difference a diabetes indication makes, employer carve-outs, and what an appeal…

35 questions
t2dm
t2dm

Type 2 diabetes: glycaemic endpoints, the SURPASS and SUSTAIN programmes, dose ranges licensed for diabetes versus obesity, and interaction with…

22 questions
shareeditfollowflag
DS
askedDr_Ravi_Selvarajah35k13719 May 2026
7Do you have the plan document or the medical policy? That is where the criteria live. – w_okoye 5 months ago
8Was a reason given in writing? The denial letter is the specification for the appeal. – lyoph_cake 6 months ago
add a comment

3 Answers

Sorted by votes
35

Answering this needs the plan, since criteria vary and a general answer is not actionable.

A peer-to-peer review — the prescriber speaking to the plan's reviewer — is available in many systems and resolves a meaningful proportion of denials that a written appeal would not.

503A versus 503B

Dimension503A503B outsourcing facility
Prescription requiredPatient-specificNot required
cGMP complianceExemptRequired
Primary regulatorState boardFDA registration and inspection
Release testingGenerally noneRequired
Operative standardUSP <795> / <797>cGMP plus USP
Practical consequencePotency varies between sitesPotency is tested before release

Submit the supporting documents with the request rather than waiting to be asked. Requests denied for insufficient information are denials that a complete submission would have avoided.

Appeal windows and renewal periods are defined in plan documents and are strictly applied.

The denial reason is the appeal specification. Address it directly.

shareimprove this answerflag
PH
answeredpetra_hovland35k3820 Jun 2026
7Worth adding that the medical policy document is public and states the criteria explicitly. – RP_C18 2 days ago
8Worth flagging that a verbal assurance from a call centre binds nobody. – a_lindgren 2 months ago
add a comment
Sponsored

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample
Sponsored — paired listing

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem
23

Specifically, this is a paperwork problem with a paperwork solution, and framing it that way is the most useful thing anyone can do.

Each criterion must be evidenced in the clinical record, dated, before the request. A criterion asserted in a covering letter but absent from the notes is the commonest reason for a denial.

Stated carefully, approvals expire. Note the renewal date when the approval arrives, because a lapse mid-treatment is administratively identical to a fresh denial.

Medical policies stating prior-authorisation criteria are published by plans and are obtainable before submission.

Get the criteria first. A request written blind is a request written badly.

shareimprove this answerflag
DS
answeredDr_Ravi_Selvarajah35k1377 Jun 2026
6Any figure for how often peer-to-peer review resolves a denial? It seemed high when I did it. – bufferline42 6 months ago
add a comment
17

Start by obtaining the criteria before the request is submitted, because a request written blind is a request written badly.

Where prerequisite therapy is required, the record needs the agent, the dates, the dose and the reason it was stopped. "Tried and failed" without those four elements is not documentation.

Track the deadlines. Appeal windows are finite, and a well-founded appeal filed late is worth nothing at all.

A substantial proportion of denials cite incomplete documentation rather than clinical non-eligibility, which is why complete first submissions matter.

Evidence every criterion in the dated record, not in a covering letter.

shareimprove this answerflag
SL
answeredsecond_lot9.4k1416 Jul 2026

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.